San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Atreo is raising $4,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ryan Harrison played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Atreo
Atreo has embraced and focused on a simple mantra: Time Better Spent. Time is the most valuable asset for our clients, Atreo team members, and most critically for patients enrolled in clinical trials. Our RTSM solutions will help bring lifesaving therapeutics to market faster, more collaboratively, and with significantly higher quality, ensuring Time Better Spent becomes the expectation of Atreos partners and patients. Our vision is to bring smarter, healthier solutions to market faster. Our mission is to develop the most advanced, agile, and smartest RTSM solution in the market.

To learn more about Atreo, visit http://atreo.io/

Contact:
Ryan Harrison, Chief Executive Officer
978-852-5489
https://www.linkedin.com/in/ryanharrisonrmc/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved